|1.||Funakoshi, Akihiro: 6 articles (08/2006 - 07/2002)|
|2.||Miyasaka, Kyoko: 6 articles (08/2006 - 07/2002)|
|3.||Ohta, Minoru: 4 articles (08/2006 - 07/2002)|
|4.||Kanai, Setsuko: 4 articles (08/2006 - 07/2002)|
|5.||Rehfeld, J F: 3 articles (10/2009 - 06/2000)|
|6.||Samuel, Isaac: 3 articles (11/2004 - 11/2003)|
|7.||Zaheer, Smita: 3 articles (11/2004 - 11/2003)|
|8.||Zaheer, Asgar: 3 articles (11/2004 - 11/2003)|
|9.||D'Amato, M: 3 articles (11/2002 - 03/2001)|
|10.||Xu, Qi: 2 articles (10/2014 - 09/2012)|
10/01/1998 - "Although blockade of the CCK-A receptor could be considered to exacerbate chronic pancreatitis due to possible inhibition of the trophic action of CCK, our results suggest that CCK-A receptor antagonists may not be detrimental to chronic pancreatitis."
07/01/2002 - "The therapeutic efficacy of a CCK-A receptor antagonist, loxiglumide, in patients with painful acute attacks of chronic pancreatitis was evaluated. "
10/01/1998 - "Effect of FK480, a CCK-A receptor antagonist, on spontaneously developed chronic pancreatitis in WBN/Kob rats."
07/01/2002 - "Clinical evaluation of oral administration of a cholecystokinin-A receptor antagonist (loxiglumide) to patients with acute, painful attacks of chronic pancreatitis: a multicenter dose-response study in Japan."
03/01/1997 - "The present studies were undertaken to evaluate the involvement of endogenous CCK and the CCK-A receptors in the development of severe acute pancreatitis induced in Otsuka Long-Evans Tokushima Fatty (OLETF) rats that have a selective defect in the CCK-A receptor. "
03/01/2000 - "The CCK-A receptor antagonist might be therapeutically useful in acute pancreatitis by stopping the vicious circle."
03/01/1998 - "These observations indicate that the absence of the CCK-A receptor did not modify the acute phase of pancreatitis but significantly retarded regeneration of the pancreatic tissue."
10/01/1995 - "Changes in gene expression of cholecystokinin-A receptor after induction of pancreatitis by pancreatic duct occlusion in rats."
01/01/2004 - "In the present study, we show for the first time a progressive rise in CCK-A receptor protein expression in ligation-induced acute pancreatitis in rats. "
|3.||Schizophrenia (Dementia Praecox)
04/01/2007 - "Association study between the cholecystokinin A receptor gene and schizophrenia in the Japanese population."
07/01/2015 - "Cholecystokinin A receptor (CCK-AR) gene polymorphism is being increasingly reported in schizophrenia. "
10/01/2014 - "To find the risk loci on cholecystokinin A receptor gene (CCKAR) - a schizophrenia candidate gene by using the deep sequencing and then analyze the variations. "
10/01/2014 - "[Deep sequencing for cholecystokinin a receptor gene to get loci associated with schizophrenia]."
10/01/2009 - "An intron 1 polymorphism in the cholecystokinin-A receptor gene associated with schizophrenia in males."
10/01/2007 - "The present study assessed the dose-dependency of this response and the effect of two selective CCK(1) receptor antagonists, with different abilities to cross the blood-brain barrier (BBB), on PEG-CCK(9)-induced anorexia. "
03/05/2008 - "Jejunal LA infusion also reduced food intake in CCK-A receptor-deficient OLETF rats, suggesting that CCK signaling pathway is not critical for intestinal LCFA-induced anorexia. "
03/17/1994 - "The present study compared the patterns of c-fos protein-like immunoreactivity (FLI) induced in rat brain by CCK and the indirect 5HT agonist dexfenfluramine (DFEN), as well as the ability for devazepide, a CCK-A receptor antagonist, to antagonize both anorexia and FLI induced by these agents. "
03/01/1999 - "Devazepide, a CCK(A) receptor antagonist, appeared to interact with tropisetron in the anorectic responses to IMB, blunting the usual remediation of IMB anorexia by tropisetron. "
05/01/2000 - "To test the possibility that cholecystokinin (CCK) mediates anorexia induced by IL-1 beta and LPS, mice trained to poke their noses in a hole to obtain a food reward according to a fixed ratio (1 reward per 20 actions) were pretreated with the CCK-A receptor antagonist L364,718 (at 1 mg/kg) or with the CCK-B receptor antagonist L365,260 (50 microg/kg) before being injected with LPS (100 microg/kg) or IL-1 beta (20 microg/kg). "
11/01/2002 - "The genetic variations of cholecystokinin A receptor (CCK-AR) in patients having gallstones and the molecular mechanisms of this polymorhpism were examined. "
05/01/2005 - "Thus the lowered expression of CCK-A receptor is probably the cause of hypomotility in patients with gallstones and diabetes mellitus."
05/01/2005 - "The gene expression of CCK-A receptor on the smooth muscle of the gallbladder may decrease more significantly in patients with gallstone and diabetes mellitus than in those with gallstone only; this result is consistent with the decreased motility. "
05/01/2005 - "Correlation between gene expression of CCK-A receptor and emptying dysfunction of the gallbladder in patients with gallstones and diabetes mellitus."
05/01/2005 - "The aim of this study was to investigate the gene expression of cholecystokinin-A (CCK-A) receptor in patients with gallstones and diabetes mellitus and its correlation with the hypomotility of the gallbladder. "
|3.||Messenger RNA (mRNA)
|4.||Cholecystokinin B Receptor
|5.||Cholecystokinin A Receptor